A major problem in the treatment of cancer arises from quiescent cancer cells that are relatively insensitive to most chemotherapeutic drugs and radiation. Such residual cancer cells can cause tumor regrowth or recurrence when they reenter the cell cycle. Earlier studies showed that levels of the serine/theronine kinase Mirk/dyrk1B are elevated up to 10-fold in quiescent G(0) tumor cells.
View Article and Find Full Text PDFBerl Munch Tierarztl Wochenschr
June 1967
Hoppe Seylers Z Physiol Chem
March 1968
Naunyn Schmiedebergs Arch Pharmakol Exp Pathol
September 1967
Zentralbl Veterinarmed B
December 1965
Munch Med Wochenschr
September 1965
Arzneimittelforschung
March 1963
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol
November 1998
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol
November 1998
Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr
November 1998